ES479269A1 - Procedimiento para la preparacion de 4,6-dihalo esteroides. - Google Patents

Procedimiento para la preparacion de 4,6-dihalo esteroides.

Info

Publication number
ES479269A1
ES479269A1 ES479269A ES479269A ES479269A1 ES 479269 A1 ES479269 A1 ES 479269A1 ES 479269 A ES479269 A ES 479269A ES 479269 A ES479269 A ES 479269A ES 479269 A1 ES479269 A1 ES 479269A1
Authority
ES
Spain
Prior art keywords
chloro
fluoro
hydroxy
hydrogen
pregn
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES479269A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntex USA LLC
Original Assignee
Syntex USA LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex USA LLC filed Critical Syntex USA LLC
Publication of ES479269A1 publication Critical patent/ES479269A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Nuevos corticosteroides. Más concretamente se refiere a preg-4-enos que están sustituidos en la posición 4 flúor o cloro y están opcionalmente sustituidos. Entre otros, en C6 por flúor o cloro. Los compuestos son agentes anti-inflamatorios tópicamente activos en los mamíferos. El invento se refiere también a composiciones farmacéuticamente activas que comprenden el compuesto del invento en combinación con, por lo menos, un excipiente aceptable en farmacia.
ES479269A 1978-04-05 1979-04-04 Procedimiento para la preparacion de 4,6-dihalo esteroides. Expired ES479269A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US89364178A 1978-04-05 1978-04-05

Publications (1)

Publication Number Publication Date
ES479269A1 true ES479269A1 (es) 1980-01-16

Family

ID=25401847

Family Applications (1)

Application Number Title Priority Date Filing Date
ES479269A Expired ES479269A1 (es) 1978-04-05 1979-04-04 Procedimiento para la preparacion de 4,6-dihalo esteroides.

Country Status (16)

Country Link
EP (1) EP0004766A3 (es)
JP (1) JPS54135762A (es)
AR (1) AR224124A1 (es)
AT (1) ATA251679A (es)
AU (1) AU4575379A (es)
CS (1) CS209915B2 (es)
DK (1) DK136379A (es)
ES (1) ES479269A1 (es)
FI (1) FI791080A (es)
GR (1) GR66483B (es)
IL (1) IL56989A0 (es)
IT (1) IT7967708A0 (es)
NO (1) NO791143L (es)
PL (1) PL214677A1 (es)
PT (1) PT69410A (es)
ZA (1) ZA791637B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4340538A (en) * 1980-07-21 1982-07-20 The Upjohn Company Process for producing 6α-fluoro-Δ1,4 -3-keto steroids
CN103391945B (zh) * 2011-03-15 2016-11-09 奇斯药制品公司 异噁唑烷衍生物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3125591A (en) * 1964-03-17 Derivatives thereof
FR1273890A (fr) * 1960-05-14 1961-10-20 Chimiotherapie Lab Franc Procédé de préparation de stéroïdes 21-bromés
US3169131A (en) * 1963-03-29 1965-02-09 Upjohn Co Process for the preparation of 4-fluorohydrocortisone, 21-acylates and 16-substituted derivatives thereof, and intermediates produced in the preparation thereof

Also Published As

Publication number Publication date
PL214677A1 (es) 1980-01-02
EP0004766A3 (en) 1979-10-31
GR66483B (es) 1981-03-24
FI791080A (fi) 1979-10-06
JPS54135762A (en) 1979-10-22
IL56989A0 (en) 1979-07-25
AU4575379A (en) 1979-10-11
PT69410A (fr) 1979-04-01
DK136379A (da) 1979-10-06
IT7967708A0 (it) 1979-04-04
AR224124A1 (es) 1981-10-30
ATA251679A (de) 1982-04-15
EP0004766A2 (en) 1979-10-17
NO791143L (no) 1979-10-08
ZA791637B (en) 1980-11-26
CS209915B2 (en) 1981-12-31

Similar Documents

Publication Publication Date Title
AU584340B2 (en) Topical treatment of inflammatory disorders
GB1497985A (en) Oxazolo-pyridines their preparation and use and compositions containing them
ES8401942A1 (es) Procedimiento para la preparacion de n-piridil-amidas de acido 1-fenil-ciclopentancarboxilico.
ES8506575A1 (es) Procedimiento para la preparacion de nuevos derivados de acidos fenilalcanoicos.
GB1471910A (en) Lysine salt
ES479269A1 (es) Procedimiento para la preparacion de 4,6-dihalo esteroides.
GB1308028A (en) Thiazolylbenzoic acid derivatives and a process for their manufactur
FR2355822A1 (fr) Derives d'esters de l'acide indolacetique. utiles comme anti-inflammatoires et analgesiques
GB1265279A (es)
GB1420739A (en) 3-alkenyl dibenzo-b,d-pyran compounds
ES427115A1 (es) Procedimiento de preparacion de nuevos derivados del acido acetico.
AU566898B2 (en) Benz (5,6) isoindolo(z,1-b)isoquinoline -8,13-dione and their use as anti-cancer agents
IE34401B1 (en) New 21,21-dichloro-steroids
ES479270A1 (es) Un procedimiento para la preparacion de acidos 4-halo etia- nicos y sus derivados.
GB1438260A (en) Sulphoxides and sulphones processes for their preparation and compositions containing them
ES8704951A1 (es) Un procedimiento para la preparacion de nuevos derivados penem.
GB1513280A (en) Therapeutic pyrazole derivatives
AU582206B2 (en) Imidazole derivatives,their preparation and therapeutic use
GB1505701A (en) 2-chloro-6beta-fluoropregnanes
EP0005055A3 (en) 6,11-dihydrodibenzo-thiepin-11-ones and their s-oxides, methods for their preparation and pharmaceutical compositions containing them
FR2257275A1 (en) Alkaloid salts of para chlorophenoxy isobutyric acid - useful for inhibiting thromboses and as hyperlipaemics
IE780933L (en) Pregnene derivatives
ES2000209A6 (es) Un procedimiento para preparar derivados de benceno
DE3571394D1 (en) A (-) campholenic acid ester of salicylic acid having mucosecretolytic, anti-inflammatory, analgesic antipyretic activity, suitable to provide pharmaceutically acceptable salts; a process for its preparation and pharmaceutical compositions containing the ester or the salts thereof
DE3263316D1 (en) New compound having analgesic, antiinflammatory and mucoregulating activities, process for its production and relative pharmaceutical compositions